The aim of this research is to define the features that distinguish the growth and differentiation of squamous carcinoma cells (SqCC) from those of non-neoplastic keratinocytes, in terms of altered sensitivities to physiological modulators of these processes, in an effort to provide new targets for anticancer treatment. This question shall be addressed by exploiting the fact that phenotypically heterogenous human SqCC cell lines as well as normal epidermal cells can be cultured in vitro under defined conditions and a variety of modulators of growth and differentiation have been identified. Moreover, primary explants of surgical specimens of naturally occurring SqCC's and surrounding non-neoplastic epithelium will be used to confirm the generality of any findings, as well as provide characteristics of in vitro growth and differentiation as corrollaries of the clinical biology of the tumors. Secondly, the genetic basis for the transformed phenotype (i.e. abnormal regulation of growth and differentiation) of SqCCs will be explored, by making use of DNA transfection methods. Thus, selected oncogenes will be transfected into normal human keratinocytes, in order to chart specific changes of growth and differentiation. In addition, an attempt will be made to detect transforming sequences in the genome of SqCCs by transfection of genomic DNA of these tumors into murine keratinocytes, using a number of phenotypic characteristics of SqCCs as end points.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA041556-06
Application #
3182180
Study Section
Pathology B Study Section (PTHB)
Project Start
1986-07-01
Project End
1995-05-31
Budget Start
1992-06-01
Budget End
1993-05-31
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Xie, Wen; Aisner, Seena; Baredes, Soly et al. (2013) Alterations of Smad expression and activation in defining 2 subtypes of human head and neck squamous cell carcinoma. Head Neck 35:76-85
Cohen-Solal, Karine A; Merrigan, Kim T; Chan, Joseph L-K et al. (2011) Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-?-mediated growth inhibition. Pigment Cell Melanoma Res 24:512-24
Tan, Antoinette R; Alexe, Gabriela; Reiss, Michael (2009) Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer? Breast Cancer Res Treat 115:453-95
Bharathy, Savita; Xie, Wen; Yingling, Jonathan M et al. (2008) Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype. Cancer Res 68:1656-66
Padgett, Richard W; Reiss, Michael (2007) TGFbeta superfamily signaling: notes from the desert. Development 134:3565-9
Ge, Rongrong; Rajeev, Vaishali; Ray, Partha et al. (2006) Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo. Clin Cancer Res 12:4315-30
Subramanian, Gayathri; Schwarz, Roderich E; Higgins, Linda et al. (2004) Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Cancer Res 64:5200-11
Xie, Wen; Bharathy, Savita; Kim, David et al. (2003) Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysis. Oncol Res 14:61-73
Liu, Chenghai; Gaca, Marianna D A; Swenson, E Scott et al. (2003) Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta ) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J Biol Chem 278:11721-8
Xie, Wen; Mertens, Joachim C; Reiss, Daniel J et al. (2002) Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. Cancer Res 62:497-505

Showing the most recent 10 out of 38 publications